Mycobacterial Growth Inhibition Assay (MGIA) as a Host Directed Diagnostic Tool for the Evaluation of the Immune Response in Subjects Living With Type 2 Diabetes Mellitus

Mycobacterial Growth Inhibition Assay (MGIA) as a Host Directed Diagnostic Tool for the Evaluation of the Immune Response in Subjects Living With Type 2 Diabetes Mellitus

The lack of efficient and cost-effective diagnostic tools contributes to poor control of tuberculosis in endemic countries. Moreover, host biological processes influence susceptibility, and infection resolution. It is well known that comorbidities such as type 2 diabetes mellitus (DM2) affect the ho...

Full description

Bibliographic Details
Main Authors: Miriam Bobadilla-del-Valle, Francisco Leal-Vega, Pedro Torres-Gonzalez, Anabel Ordaz-Vazquez, Maria de Lourdes Garcia-Garcia, Ma. de los Angeles Tovar-Vargas, Guadalupe Delgado-Sanchez, Paola Del Carmen Guerra De Blas, Robert S. Wallis, Alfredo Ponce-De-León, José Sifuentes-Osornio
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
host-directed diagnostic tool
Mycobacterium tuberculosis
diabetes mellitus type 2 (DM2)
glycemic control
mycobacterial growth inhibition assay
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2021.640707/full

Internet

https://www.frontiersin.org/articles/10.3389/fcimb.2021.640707/full

Similar Items